Johan Fransson

Johan Fransson is an accomplished professional in the biotechnology and pharmaceutical industries, currently serving as Executive Director at Merck since November 2023. Previously, Johan held the position of Executive Director of Antibody and Protein Therapeutics at Prometheus Biosciences, Inc., where efforts focused on precision medicine for immune-mediated diseases. Other notable roles include Head of Preclinical Research & Development at Deep Genomics, Director of Antibody Discovery and Development at Northern Biologics, and Principal Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson. Johan has significant expertise in therapeutic development, antibody discovery, and managing cross-functional teams, leading to successful candidate declarations and innovative research outcomes. Johan holds a Ph.D. in Immunotechnology and an M.S. in Chemical Engineering, both from Lund University.